David P. Schenkein, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 38,966 shares at $28.82 ($1.1M) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Open-market sale of $1.1M AGIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.82 | 18,966 | $547K | 48.6% |
| 2 | $28.82 | 18,966 | $547K | 48.6% |
| 3 | $29.49 | 1,034 | $30K | 2.7% |
| Total | $28.84 avg | 38,966 | $1.1M | 100% |
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |